Evidence map›Paper›PMID 25840499›Full record

Trial reportAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2015

Factors associated with high short-acting β2-agonist use in urban children with asthma.

Arlene M Butz, Jean Ogborn, Shawna Mudd, Jeromie Ballreich, Mona Tsoukleris, Joan Kub, Melissa Bellin, Mary Elizabeth Bollinger

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01981564 (Asthma Express Intervention to Bridge Emergency to Primary Care for High Risk Children With Asthma), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01981564 nacompletednot on this map

Asthma Express Intervention to Bridge Emergency to Primary Care for High Risk Children With Asthma

TypeinterventionalSponsorJohns Hopkins UniversityRan2013 to 2018Enrolled222ConditionsAsthmaArmsAsthma Express Intervention, Standard Asthma Education Control Group
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Salivary cotinine measurement for all children with persistent asthma: spit matters.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2016
    Trial
  4. Review
  5. Review
  6. Short-acting βERJ open research · 2023
    Article
  7. Short-acting βPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  8. Article
  9. Article
  10. Exploring the barriers and incentive architecture for modifying smoke exposures among asthmatics.The Journal of asthma : official journal of the Association for the Care of Asthma · 2019
    Article
  11. Factors associated with poor controller medication use in children with high asthma emergency department use.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2017
    Article
  12. Caregiver perception of asthma management of children in the context of poverty.The Journal of asthma : official journal of the Association for the Care of Asthma · 2017
    Article
  13. Article
  14. Review
  15. Article
  16. Asthma Home Management in the Inner-City: What can the Children Teach us?Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Arlene M ButzDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: abutz@jhmi.edu.
Jean OgbornDepartment of Pediatric Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Shawna MuddThe Johns Hopkins University School of Nursing, Baltimore, Maryland.
Jeromie BallreichThe Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Mona TsouklerisThe University of Maryland School of Pharmacy, Baltimore, Maryland.
Joan KubThe Johns Hopkins University School of Nursing, Baltimore, Maryland.
Melissa BellinThe University of Maryland School of Social Work, Baltimore, Maryland.
Mary Elizabeth BollingerDepartment of Pediatrics, The University of Maryland School of Medicine, Baltimore, Maryland.
Johns Hopkins Medicine · USUniversity of Maryland, Baltimore · USJohns Hopkins University · US

Funding

TRAINING IN HEALTH SERVICES RESEARCHT32HS000029 · AHRQ · JOHNS HOPKINS UNIVERSITY · PI DY, SYDNEY MORSS · 1987 to 2024
$8.3M
Institute for Clinical and Translational ResearchUL1TR000424 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2012 to 2012
$6.0M
Asthma Express: Bridging Emergency to Primary Care in Underserved ChildrenR01NR013486 · NINR · JOHNS HOPKINS UNIVERSITY · PI BUTZ, ARLENE MANNS · 2013 to 2017
$2.3M
AHRQ HHS T32 HS000029NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR 000424-06NINR NIH HHS R01 NR013486
6 · The paper itself

Abstract

backgroundOne goal of guideline-based asthma therapy is minimal use of short-acting β₂ agonist (SABA) medications. Inner-city children with asthma are known to have high SABA use.

objectiveTo examine factors associated with high SABA use in inner-city children with asthma.

methodsOne hundred inner-city children with persistent asthma were enrolled into a randomized controlled trial of an emergency department (ED) and home intervention. All children underwent serologic allergen specific IgE and salivary cotinine testing at the ED enrollment visit. Pharmacy records for the past 12 months were obtained. Number of SABA fills during the past 12 months was categorized into low- to moderate- vs high-use groups. SABA groups were compared by the number of symptom days and nights, allergen sensitization, and exposures. Regression models were used to predict high SABA use.

resultsMean number of SABA fills over 12 months was 3.12. Unadjusted bivariate analysis showed that high SABA users were more than 5 times more likely to have an asthma hospitalization, almost 3 times more likely to have an asthma intensive care unit admission, and more than 3 times more likely to have prior specialty asthma care or positive cockroach sensitization than low to moderate SABA users. In the final regression model, for every additional inhaled corticosteroid fill, a child was 1.4 times more likely and a child with positive cockroach sensitization was almost 7 times more likely to have high SABA use when controlling for prior intensive care unit admission, receipt of specialty care, child age, and income.

conclusionProviders should closely monitor SABA and controller medication use, allergen sensitization, and exposures in children with persistent asthma.

trial registrationClinicalTrials.gov, identifier NCT01981564.

Indexed as

Adrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsAsthmaChildChild, PreschoolFemaleHumansMaleUrban PopulationAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic Agents

Identifiers

PMID25840499
PMCPMC4426068
OpenAlexW2140565961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.